BSI-401
BSI-401 is an orally active PARP-1 inhibitor. BSI-401 alone and in synergism with Oxaliplatin inhibits pancreatic cancer[1].
Product Specifications
CAS Number
142404-10-2
UNSPSC
12352005
Target
PARP
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Field of Research
Cancer
Smiles
O=C1C=CC2=C(I)C([N+]([O-])=O)=CC=C2O1
Molecular Formula
C9H4INO4
Molecular Weight
317.04
References & Citations
[1]Melisi D, et al. Oral poly (ADP-ribose) polymerase-1 inhibitor BSI-401 has antitumor activity and synergizes with oxaliplatin against pancreatic cancer, preventing acute neurotoxicity. Clin Cancer Res. 2009 Oct 15;15 (20) :6367-77.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PARP1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MR223884L4 10 µg
Zfp809 (NM_001164624) Mouse Tagged Lenti ORF Clone
Sign In for Pricing
View Details 
254366 10 mg
2-Methylthioadenosine diphosphate trisodium salt discontinued. See 418880
Sign In for Pricing
View Details 
251834-PE 100 µL
SMAD7 (SMAD Family Member 7, CRCS3, FLJ16482, MADH7, MADH8) (PE)
Sign In for Pricing
View Details